Penalized logistic regression with low prevalence exposures beyond high dimensional settings.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 30 10 2018
accepted: 05 05 2019
entrez: 21 5 2019
pubmed: 21 5 2019
medline: 6 2 2020
Statut: epublish

Résumé

Estimating and selecting risk factors with extremely low prevalences of exposure for a binary outcome is a challenge because classical standard techniques, markedly logistic regression, often fail to provide meaningful results in such settings. While penalized regression methods are widely used in high-dimensional settings, we were able to show their usefulness in low-dimensional settings as well. Specifically, we demonstrate that Firth correction, ridge, the lasso and boosting all improve the estimation for low-prevalence risk factors. While the methods themselves are well-established, comparison studies are needed to assess their potential benefits in this context. This is done here using the dataset of a large unmatched case-control study from France (2005-2008) about the relationship between prescription medicines and road traffic accidents and an accompanying simulation study. Results show that the estimation of risk factors with prevalences below 0.1% can be drastically improved by using Firth correction and boosting in particular, especially for ultra-low prevalences. When a moderate number of low prevalence exposures is available, we recommend the use of penalized techniques.

Identifiants

pubmed: 31107924
doi: 10.1371/journal.pone.0217057
pii: PONE-D-18-31200
pmc: PMC6527211
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0217057

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Int J Epidemiol. 2013 Feb;42(1):308-17
pubmed: 23230299
Int J Cancer. 1991 Sep 30;49(3):335-40
pubmed: 1655658
Epidemiology. 2012 Sep;23(5):706-12
pubmed: 22766751
Stat Med. 2014 Dec 30;33(30):5413-32
pubmed: 25074480
Am J Epidemiol. 2018 Apr 1;187(4):864-870
pubmed: 29020135
Epidemiology. 2017 Mar;28(2):249-257
pubmed: 27922533
J Postgrad Med. 2016 Jan-Mar;62(1):26-31
pubmed: 26732193
Stat Med. 2006 Dec 30;25(24):4216-26
pubmed: 16955543
PLoS Med. 2010 Nov 16;7(11):e1000366
pubmed: 21125020
Methods Inf Med. 2014;53(6):419-27
pubmed: 25112367
Am J Epidemiol. 2014 Jan 15;179(2):252-60
pubmed: 24173548
Int J Epidemiol. 1999 Aug;28(4):631-9
pubmed: 10480689
Biom J. 2018 May;60(3):431-449
pubmed: 29292533
Bioinformatics. 2012 May 15;28(10):1368-75
pubmed: 22467913
BMC Med Res Methodol. 2016 Aug 22;16:103
pubmed: 27549803
Biometrics. 2006 Dec;62(4):961-71
pubmed: 17156269
Drug Saf. 2002;25(9):677-87
pubmed: 12137561
Stat Med. 2002 Aug 30;21(16):2409-19
pubmed: 12210625

Auteurs

Sam Doerken (S)

Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
Freiburg Center for Data Analysis and Modeling, University of Freiburg, Freiburg, Germany.

Marta Avalos (M)

University of Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR1219, Bordeaux, France.
SISTM team, INRIA Bordeaux-Sud-Ouest, Talence, France.

Emmanuel Lagarde (E)

University of Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR1219, Bordeaux, France.

Martin Schumacher (M)

Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH